Resident Net Home

WEEK AHEAD


Quick Links

NMH Phone Numbers

Remote Access
Amion
WebPaging
Procedure Log
Rotation Evaluations
Hopkins Modules
Clinical Tools and Guidelines
Rotation Guidelines
NMH Antibiotic Guidelines:
     Empiric | Gm+ | Gm-
Clinical Practice Resouces

Conference Links

Past Conferences

How to link to Noon Conference

Grand Rounds Online


The Director's Chair

Resident Research
Program Policies
ACLS Simulator
Our Class Pictures
Visiting Residents
Self-Learning and Research Links
Galter Library
Blackboard Academic Suite
Career Resources
PDA and Computer Software


Resident Links

GME Benefits
VA Information
Powerchart Tips
Epic Tips
Needle Stick
Discharge Summaries






Pulmonary

Educational Plan: A competency based development of knowledge and skills in Pulmonology through clinical experience, bedside teaching, didactic conferences and readings to achieve competence, proficiency and the foundation for mastery. 

Educational Methods:

Clinical Information and Didactics

  • Residents will function as integral members of the Pulmonary Consultation/Inpatient Service.
  • Scheduling of rounds will be determined on a daily basis with the faculty member.  Residents will be permitted to leave at 6:00 pm, in the event that rounds run later into the evening.  Residents will not be required to work on weekends.



Monday

Tuesday

Wednesday

Thursday

Friday

AM

7:30 am

Morning Report

9:00 am

Pulmonary Morning Report (Feinberg 9-740, MICU conf room)

7:30 am

Grand Rounds

8:00 am

Multi-disciplinary ThoracicOncology Conf (Galter 21, Lurie Conf Rm)

9:00 am

Pulmonary Morning Report (Feinberg 9-740, MICU conf room)

7:30 am

Morning Report 

7:30 am

Morning Report 

9:00 am

Pulmonary Morning Report (Feinberg 9-740, MICU conf room)

PM

1:00 pm

Research Conference (Prentice 156)

12:00 pm

Core Conference (Prentice 156)

1:00 pm

Grand Rounds/Journal Club (Prentice 156)




  • Residents will be expected to attend all Pulmonary specific conferences scheduled above.
  • NMH Pulmonary Consultation/In-patient Service Fellow Pager:  312-695-6448

Evaluation Tools: Click here

Goals and Objectives:  Review the 6 core competencies that apply to your clinical rotations.Click here.

Practice Based Learning and Improvement
  PGY1: Incorporate regular chart review and patient follow up to learn from your clinical care.  Teach and mentor students.  
  PGY2/3: Incorporate evidence based medicine into clinical decision making.  Review the latest research pertaining to your your patients.  Teach and mentor students and interns.
 
Systems Based Practice
  PGY1: Work in a multi-disciplinary team to provide high quality coordinated care.   Ensure accurate and timely documenation through the use of the electronic medical record.
  PGY2/3: Use knowledge and skills in quality improvement and patient safety to deliver safe and effective care.  Apply team leadership skills in appropriate settings.  Practice cost effective medicine with an awareness of health care economics and patient insurance status. 
 
Interpersonal Skills and Communication
  PGY1: Use effective listening skills with patients and health care providers.  Elicit and provide information using effective nonverbal, explanatory, questioning, and writing skills.
  PGY2/3: Develop interpersonal and communication skills necessary to run an effective clincal team in the ambulatory.  Role model and teach effective communication techniques. 
 
Professionalism
  PGY1: Carry out your professional responsibilities in a timely manner.  Adhere to the ethical principles of a patient-centered practice.  Be sensitive to a diverse patient population and health care staff. 
  PGY2/3: Understand how biases influence clinical care, patient-physician interactions and health team interactions.  Role model and provide feedback to students and interns the principles of humanism in medicine.
 
Patient Care and Medical Knowledge
  1. Become familiar with the diagnosis and management of both common and unusual disorders affecting the chest. 
  2. Learn basic pulmonary physiology related to pulmonary function testing and gain experience in interpretation. 
  3. Learn about the role of flexible bronchoscopy in the evaluation of lung disease and observe bronchoscopic procedures.

PGY1

  • Describe basic patterns of parenchymal infiltration on chest x-ray and chest CT scan, including alveolar, reticular-nodular and ground-glass opacification.
  • Recognize the features of obstructive and restrictive ventilatory defects on pulmonary function testing, and become familiar with the American Thoracic Society criteria for diagnosis of each of these patterns.

PGY2,3

  • Formulate a differential diagnosis of common presenting symptoms, signs and laboratory findings, such as cough, sputum production, dyspnea, wheezing, hemoptysis, chest pain, hypoxemia, polycythemia, and others.

Understand Definition, Pathophysiology, Epidemiology, Clinical History, Physical Exam, Laboratory and Imaging findings, Diagnostic criteria and Management of the following:

  • Obstructive lung diseases, including asthma, bronchitis, emphysema, bronchiectasis and cystic fibrosis.
  • Pulmonary malignancy, primary and metastatic.
  • Pulmonary infections, including community-acquired bacterial and atypical pneumonias, hospital-acquired pneumonias, pyogenic lung abscess, tuberculosis, fungal disease, and infections in immunocompromised hosts (including patients receiving chemotherapy for cancer or immunosuppression following organ transplantation, and patients infected with HIV).
  • Diffuse interstitial lung diseases.
  • Pulmonary vascular disease, including pulmonary embolism, pulmonary hypertension, pulmonary vasculitis and alveolar hemorrhage syndromes.
  • Occupational and environmental lung diseases.
  • Radiation- and drug-induced lung disease.
  • Pulmonary manifestations of systemic diseases, including collagen vascular diseases.
  • Neuromuscular diseases.
  • Disorders of the pleura and mediastinum.
  • Sleep disorders.
  • Describe the indications, contraindications, utility and limitations of flexible bronchoscopy in the evaluation of patients with known or suspected pulmonary disease.

­­­­­­­­­­­­­­References: Top References

  • Laviolette M, Malmstrom K, Lu S, et al. Montelukast added to inhaled beclomethasone in treatment of asthma. AJRCCM 1999;160:1862-68.
    • This randomized, double-blinded study supports the addition of a leukotriene inhibitor for asthmatics with inadequate symptom control with inhaled corticosteroid alone.
  • Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma.NEJM 1998;339:1194-200.
    • Noteworthy for being one of the studies showing that a portion of patients with asthma go on to develop fixed airway obstruction.
  • Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. AJRCCM 2001;163:1730-54.
    • Latest recommendations from the ATS.
  • ATS / ERS Task Force: Standards for the diagnosis and treatment of patients with COPD: A summary position of the ATS / ERS position paper. Eur Respir J 2004;23:932-46.
    • This is an abbreviated summary of a serially updated web document:
  • American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias.   AJRCCM 2002;165:277-304.
    • Written to standardize the diagnostic criteria and terminology for idiopathic interstitial pneumonias, this article nicely summarizes the clinical, radiologic, and histologic features of the ILD alphabet soup.
  • Channick RN, Simonneau G, Sitbon O, et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study.   Lancet 2001;358:1119-23 
    • First study of chronic bosentan in 32 patients with primary or scleroderma-related pulmonary hypertension.   Over the 12 weeks of the study, bosentan was well-tolerated and improved cardiac index and exercise capacity (70 meter gain in 6-minute walk). Similar results were obtained in a subsequent larger study of 213 patients (Rubin LJ et al. NEJM 2002; 346:896-903).
  • Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of COPD. NEJM 1995;333:817-22.
    • Landmark prospective, randomized study found use of NIPPV in selected patients with COPD exacerbations resulted in fewer intubations, complications, days in hospital, and lower in-hospital mortality compared to standard treatment.
  • Wells PS, Anderson DR, Rodger M, et al. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med 2001;135:98-107.  
    • Large prospective cohort study using the SimpliRED d-dimer assay (which has sensitivity lower than, and specificity higher than, most other d-dimer tests) found the combination of a low clinical suspicion for PE and a negative d-dimer safely ruled out pulmonary embolism without additional testing.

Collection by Dr. Joseph Weber

For an extended list of references with direct article links, sign in to the Galter Health Library website at:

http://www.galter.northwestern.edu/guides/expand/resident-reading-lists

The ATS has also developed a excellent reference list that is posted online: www.thoracic.org/go/atsreadinglist